TFF Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing and commercializing drug products based on its patented Thin Film Freezing technology platform. Co. has two product candidates under development, TFF Voriconazole Inhalation Powder and TFF Tacrolimus Inhalation Powder. Co. is engaged in the analysis and testing of dry powder formulations of several drugs and vaccines through parenteral, topical, ocular, pulmonary and nasal applications through feasibility studies and material transfer agreements with U.S. and international pharmaceutical companies and certain government agencies. We show 17 historical shares outstanding datapoints in our TFFP shares outstanding history coverage, used to compute TFFP market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing TFFP market cap history over the course of time is important for investors
interested in comparing TFFP's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of TFFP versus a peer is one thing; comparing
TFFP market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like TFFP can fluctuate over the course of history.
With this page we aim to empower investors researching TFFP by allowing them to research the TFFP market cap history. |
Free TFFP Email Alerts:
Video: The Importance of Market Cap
